Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4536191
Max Phase: Preclinical
Molecular Formula: C20H17N3
Molecular Weight: 299.38
Molecule Type: Unknown
Associated Items:
ID: ALA4536191
Max Phase: Preclinical
Molecular Formula: C20H17N3
Molecular Weight: 299.38
Molecule Type: Unknown
Associated Items:
Canonical SMILES: c1ccc(Cn2c(Nc3ccccc3)nc3ccccc32)cc1
Standard InChI: InChI=1S/C20H17N3/c1-3-9-16(10-4-1)15-23-19-14-8-7-13-18(19)22-20(23)21-17-11-5-2-6-12-17/h1-14H,15H2,(H,21,22)
Standard InChI Key: QQZALSKVCZVWBY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 299.38 | Molecular Weight (Monoisotopic): 299.1422 | AlogP: 4.83 | #Rotatable Bonds: 4 |
Polar Surface Area: 29.85 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 6.89 | CX LogP: 5.33 | CX LogD: 5.22 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.58 | Np Likeness Score: -1.33 |
1. Sharma SH, Pablo JL, Montesinos MS, Greka A, Hopkins CR.. (2019) Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903., 29 (2): [PMID:30538066] [10.1016/j.bmcl.2018.12.007] |
Source(1):